Pages that link to "Q34563612"
Jump to navigation
Jump to search
The following pages link to Revised estimate of the prevalence of multiple sclerosis in the united states (Q34563612):
Displaying 50 items.
- New and emerging disease modifying therapies for multiple sclerosis (Q22242305) (← links)
- Diagnosis of inflammatory demyelination in biopsy specimens: a practical approach (Q24642895) (← links)
- Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis (Q24647406) (← links)
- Infection as an Environmental Trigger of Multiple Sclerosis Disease Exacerbation (Q26779416) (← links)
- Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate (Q27021147) (← links)
- Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes (Q28078621) (← links)
- Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression (Q28220405) (← links)
- Multiple sclerosis. (Q30808302) (← links)
- Multimodal nonlinear optical microscopy and applications to central nervous system imaging (Q33510696) (← links)
- Demyelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus (Q33604807) (← links)
- The prevalence of multiple sclerosis in 3 US communities (Q33610980) (← links)
- Nuclear receptors and autoimmune disease: the potential of PPAR agonists to treat multiple sclerosis (Q33644094) (← links)
- Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders (Q33674644) (← links)
- Pathologic heterogeneity persists in early active multiple sclerosis lesions (Q33804184) (← links)
- Neuroimmune interactions in a model of multiple sclerosis (Q33821426) (← links)
- Protease-activated receptor-1 activation by granzyme B causes neurotoxicity that is augmented by interleukin-1β (Q33846630) (← links)
- The role of costimulation in autoimmune demyelination (Q33943443) (← links)
- Immune regulation of multiple sclerosis by CD8+ T cells (Q34017004) (← links)
- Clinical and economic impact of a specialty care management program among patients with multiple sclerosis: a cohort study (Q34072461) (← links)
- Meningeal and cortical grey matter pathology in multiple sclerosis (Q34187428) (← links)
- Multiple sclerosis: empirical literature for the clinical health psychologist (Q34187515) (← links)
- The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service (Q34277165) (← links)
- Eye disorders in patients with multiple sclerosis: natural history and management (Q34399820) (← links)
- Disease Modifying Agents for Multiple Sclerosis (Q34508451) (← links)
- Palliative care in patients with multiple sclerosis (Q34537746) (← links)
- Regulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients (Q34645439) (← links)
- Toll-like receptors in multiple sclerosis (Q34721972) (← links)
- The science behind mobility devices for individuals with multiple sclerosis (Q34756503) (← links)
- Functional electrical stimulation as a component of activity-based restorative therapy may preserve function in persons with multiple sclerosis (Q34947787) (← links)
- Endovascular Therapy for Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis (Q35113791) (← links)
- Pain affects depression through anxiety, fatigue, and sleep in multiple sclerosis (Q35146090) (← links)
- Task-specific and general cognitive effects in Chiari malformation type I. (Q35149482) (← links)
- Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study (Q35399451) (← links)
- Social disruption induced priming of CNS inflammatory response to Theiler's virus is dependent upon stress induced IL-6 release (Q35489039) (← links)
- Statins and their potential targets in multiple sclerosis therapy (Q35537898) (← links)
- Statins as potential therapeutic agents in multiple sclerosis (Q35753051) (← links)
- Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis (Q35844748) (← links)
- Further Evaluation of the Motivational Model of Pain Self-Management: Coping with Chronic Pain in Multiple Sclerosis (Q36021927) (← links)
- Cost of multiple sclerosis by level of disability: a review of literature. (Q36081876) (← links)
- Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes (Q36148455) (← links)
- High-affinity binding of remyelinating natural autoantibodies to myelin-mimicking lipid bilayers revealed by nanohole surface plasmon resonance. (Q36158112) (← links)
- Using the international classification of functioning, disability and health to expand understanding of paralysis in the United States through improved surveillance (Q36170159) (← links)
- Perceptions of Health and Relationships to Disability Measures among People with Multiple Sclerosis (Q36198176) (← links)
- Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology (Q36327091) (← links)
- Patterns and significance of concomitant central and peripheral inflammatory demyelination (Q36474359) (← links)
- Multiple sclerosis prevalence in the United States commercially insured population (Q36706025) (← links)
- PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis (Q36767657) (← links)
- Natalizumab update (Q36769708) (← links)
- Poly(ADP-ribose) polymerase 2 contributes to neuroinflammation and neurological dysfunction in mouse experimental autoimmune encephalomyelitis (Q36808573) (← links)
- Towards the use of a lower limb exoskeleton for locomotion assistance in individuals with neuromuscular locomotor deficits (Q36943949) (← links)